Reduction in pricing still needed to ensure wider access to treatment
Last updated 23 July 2014
Melbourne, 21 July 2014 – High prices continue to represent a major barrier to affordable access of both new HIV medicines and viral load testing -- which is the best way to monitor whether treatment...
Last updated 21 July 2014
Last updated 21 March 2014
MSF calls for scale-up of ‘viral load’ monitoring to improve HIV treatment outcomes in developing countries
Global Fund and US-government PEPFAR programme must use purchasing power to get better prices for viral load tests
Last updated 10 December 2013
Concerns over Global Fund-led changes to a model which enables affordable scale up of HIV treatment
Last updated 2 December 2013
— MSF launches “See What We See” film series — 25 November, 2013, Johannesburg — The fight against HIV/AIDS has been hailed as one of the most successful public health projects in human...
Last updated 25 November 2013
As US FDA approves promising new HIV drug dolutegravir, MSF asks when people in developing countries will have access
Geneva/New York, 13 August 2013 — As the US Food and Drug Administration approved the new HIV drug dolutegravir late yesterday, international medical humanitarian organisation Médecins Sans Frontières/Doctors Without...
Last updated 13 August 2013
As host to both the AIDS conference and TPP trade talks this month, Malaysia reportedly vows to reject a TPP trade agreement that harms access to medicines; other countries should follow suit, and Malaysia...
Last updated 3 July 2013
MSF pricing analysis also extends to HIV diagnostic and monitoring tools
Last updated 2 July 2013
Kuala Lumpur, 30 June 2013 — The international medical humanitarian organisation Médecins Sans Frontières/ Doctors Without Borders (MSF) today welcomed new World Health Organization (WHO) guidelines...
Last updated 1 July 2013